http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102351812-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32622955710a511ff5d89f584662fe2f |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
filingDate | 2008-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64163c04feab7a51f14f6af9358ee60b |
publicationDate | 2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102351812-B |
titleOfInvention | Methanesulfonic acid cinepazide crystal form III and preparation method thereof |
abstract | The invention relates to a methanesulfonic acid cinepazide crystal form III and a preparation method thereof, and belongs to the field of chemical pharmaceutics. The water solubility of the prepared methanesulfonic acid cinepazide crystal form III is higher than that of an amorphous material, and the methanesulfonic acid cinepazide crystal form III is particularly suitable for injection, has higher chemical stability than the amorphous material, facilitates production of medicines, and storage and transportation of raw material medicines, improves the safety of the medicines and provides safe guarantee for clinical application of the medicines. |
priorityDate | 2008-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.